368 related articles for article (PubMed ID: 37579878)
1. Tale of two systems: the intertwining duality of fibrinolysis and lipoprotein metabolism.
Dai W; Castleberry M; Zheng Z
J Thromb Haemost; 2023 Oct; 21(10):2679-2696. PubMed ID: 37579878
[TBL] [Abstract][Full Text] [Related]
2. Apolipoproteins and lipoprotein(a) as factors modulating fibrin clot properties in patients with severe aortic stenosis.
Siudut J; Natorska J; Wypasek E; Wiewiórka Ł; Ostrowska-Kaim E; Wiśniowska-Śmiałek S; Plens K; Musialek P; Legutko J; Undas A
Atherosclerosis; 2022 Mar; 344():49-56. PubMed ID: 35134656
[TBL] [Abstract][Full Text] [Related]
3. MASP-1 of the complement system alters fibrinolytic behaviour of blood clots.
Jenny L; Noser D; Larsen JB; Dobó J; Gál P; Pál G; Schroeder V
Mol Immunol; 2019 Oct; 114():1-9. PubMed ID: 31325724
[TBL] [Abstract][Full Text] [Related]
4. Interrelationships between the fibrinolytic system and lipoproteins in the pathogenesis of coronary atherosclerosis.
Jovin IS; Müller-Berghaus G
Atherosclerosis; 2004 Jun; 174(2):225-33. PubMed ID: 15136052
[TBL] [Abstract][Full Text] [Related]
5. Blood clot contraction differentially modulates internal and external fibrinolysis.
Tutwiler V; Peshkova AD; Le Minh G; Zaitsev S; Litvinov RI; Cines DB; Weisel JW
J Thromb Haemost; 2019 Feb; 17(2):361-370. PubMed ID: 30582674
[TBL] [Abstract][Full Text] [Related]
6. Connecting impaired fibrinolysis and dyslipidemia.
Rodriguez M; Zheng Z
Res Pract Thromb Haemost; 2024 Mar; 8(3):102394. PubMed ID: 38706781
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the I4399M variant of apolipoprotein(a): implications for altered prothrombotic properties of lipoprotein(a).
Scipione CA; McAiney JT; Simard DJ; Bazzi ZA; Gemin M; Romagnuolo R; Macrae FL; Ariëns RA; Hegele RA; Auld J; Gauld JW; Boffa MB; Koschinsky ML
J Thromb Haemost; 2017 Sep; 15(9):1834-1844. PubMed ID: 28632940
[TBL] [Abstract][Full Text] [Related]
8. Clot or Not? Reviewing the Reciprocal Regulation Between Lipids and Blood Clotting.
Zhang Z; Rodriguez M; Zheng Z
Arterioscler Thromb Vasc Biol; 2024 Mar; 44(3):533-544. PubMed ID: 38235555
[TBL] [Abstract][Full Text] [Related]
9. Intensive low-density lipoprotein cholesterol lowering improves fibrin clot properties: Association with lipoproteins and C-reactive protein.
Siudut J; Ząbczyk M; Wołkow P; Polak M; Undas A; Jawień J
Vascul Pharmacol; 2022 Jun; 144():106977. PubMed ID: 35283275
[TBL] [Abstract][Full Text] [Related]
10. Endogenous fibrinolysis-Relevance to clinical thrombosis risk assessment.
Kanji R; Kubica J; Navarese EP; Gorog DA
Eur J Clin Invest; 2021 Apr; 51(4):e13471. PubMed ID: 33296082
[TBL] [Abstract][Full Text] [Related]
11. Beyond fibrinolysis: The confounding role of Lp(a) in thrombosis.
Boffa MB
Atherosclerosis; 2022 May; 349():72-81. PubMed ID: 35606079
[TBL] [Abstract][Full Text] [Related]
12. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
[TBL] [Abstract][Full Text] [Related]
13. Fibrinolysis and the control of blood coagulation.
Chapin JC; Hajjar KA
Blood Rev; 2015 Jan; 29(1):17-24. PubMed ID: 25294122
[TBL] [Abstract][Full Text] [Related]
14. [Lipoprotein (a)--link between lipid metabolism and coagulation system?].
Riesen WF
Schweiz Med Wochenschr; 1991 Dec; 121(49):1813-8. PubMed ID: 1836645
[TBL] [Abstract][Full Text] [Related]
15. Impact of lipoprotein apheresis on thrombotic parameters in patients with refractory angina and raised lipoprotein(a): Findings from a randomized controlled cross-over trial.
Khan TZ; Gorog DA; Arachchillage DJ; Ahnström J; Rhodes S; Donovan J; Banya W; Pottle A; Barbir M; Pennell DJ
J Clin Lipidol; 2019; 13(5):788-796. PubMed ID: 31353231
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and biophysical conditions for blood clot lysis.
Sabovic M; Blinc A
Pflugers Arch; 2000; 440(5 Suppl):R134-6. PubMed ID: 11005642
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR
Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
[TBL] [Abstract][Full Text] [Related]
18. Fibrin clot formation and fibrinolysis in patients with a history of coronary stent thrombosis.
Godschalk TC; Konings J; Govers-Riemslag JW; Ten Berg JM; Hackeng CM; Ten Cate H
Thromb Res; 2016 Jul; 143():58-62. PubMed ID: 27191854
[TBL] [Abstract][Full Text] [Related]
19. Structure of fibrin: impact on clot stability.
Weisel JW
J Thromb Haemost; 2007 Jul; 5 Suppl 1():116-24. PubMed ID: 17635717
[TBL] [Abstract][Full Text] [Related]
20. Relationship between lipoproteins, thrombosis, and atrial fibrillation.
Ding WY; Protty MB; Davies IG; Lip GYH
Cardiovasc Res; 2022 Feb; 118(3):716-731. PubMed ID: 33483737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
